The use of medical scribes hired to enter information into electronic health records (EHRs) has increased substantially, but can pose potential risks, according to a new article in JAMA.
The use of medical scribes hired to enter information into electronic health records (EHRs) has increased substantially, but can pose potential risks, according to a new Viewpoint article in JAMA.
According to data from the American College of Medical Scribe Specialists, in 6 years there will be 1 medical scribe for every 9 physicians in the US. However, the authors—George A. Gellert, MD, MPH, MPA; Ricardo Ramirea, LVN, and S. Luke Webster, MD, from CHRISTUS Health—view the increased use of medical scribes as a workaround of the suboptimal state of EHRs. They argue that if physician dissatisfaction with EHRs decreases because they interact with the technology less, then collective market pressure to evolve EHR usability will reduce.
“By reducing market demand and pressure on industry for needed improvements, the medical scribe industry (and inadvertently its customers) may contribute to an unintended, undesirable outcome: a deceleration and possibly stagnation in EHR technological improvement,” they write.
Furthermore, the authors expressed concerned about the use of medical scribes for computerized patient order entry (CPOE). The Joint Commission has noted that scribes may assist with EHR navigation, retrieval of diagnostic results, documentation, and coding, but cannot enter orders in a patient’s electronic record. Meanwhile, CMS has stated that it does not believe anyone should be allowed to enter orders using CPOE.
Despite the prohibition on the use of scribes for order entry, some physicians advocate the use of medical scribes for CPOE and regard it as clerical work. However, Gellert et al argue that only trained physicians can appropriately interpret decision support alerts that appear during CPOE.
The authors conclude that scribe support is not the answer to today’s inadequate EHRs. Rather, they encourage physicians to demand improved products to foster the rapid evolvement of EHRs.
“The rise of the medical scribe industry should not be a substitute for much-needed EHR innovation and transition to more highly effective and more functionally efficient EHR systems,” they write.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More